DOSE-RESPONSE STUDY OF METFORMIN AND CARDIOVASCULAR RISK-FACTORS IN TYPE-2 DIABETES

被引：0
|
作者：
GRANT, PJ [1 ]
机构：
[1] GEN INFIRM,DIV MED,DIABET & THROMBOSIS RES GRP,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND
来源：
DIABETOLOGIA | 1994年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A200 / A200
页数：1
相关论文
共 50 条
  • [31] TYPE-2 DIABETES IN THE ELDERLY - AN ASSESSMENT OF METFORMIN (METFORMIN IN THE ELDERLY)
    LALAU, JD
    VERMERSCH, A
    HARY, L
    ANDREJAK, M
    ISNARD, F
    QUICHAUD, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1990, 28 (08) : 329 - 332
  • [32] Dose-Response Effects of Insulin Glargine in Type 2 Diabetes
    Wang, Zhihui
    Hedrington, Maka S.
    Joy, Nino Gogitidze
    Briscoe, Vanessa J.
    Richardson, M. Antoinette
    Younk, Lisa
    Nicholson, Wendell
    Tate, Donna B.
    Davis, Stephen N.
    DIABETES CARE, 2010, 33 (07) : 1555 - 1560
  • [33] METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
    HOLMAN, RR
    TURNER, RC
    DIABETIC MEDICINE, 1989, 6 (02) : 180 - 180
  • [34] Kidney and Type-2 Diabetes Reducing Renal and cardiovascular Risk
    Brettschneider, Helga
    DIABETES STOFFWECHSEL UND HERZ, 2021, 30 (06): : 411 - 412
  • [35] Predictor for cardiovascular risk in patients with type-2 diabetes mellitus
    Azharuddin, Md
    Kapur, Prem
    Mishra, Ritu
    Saleem, Shakir
    Gupta, Ashok Kumar
    Adil, Mohammad
    Sharma, Manju
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 12
  • [36] RISK-FACTORS FOR PERIPHERAL VASCULAR-DISEASE IN HYPERTENSIVE SUBJECTS WITH TYPE-2 DIABETES-MELLITUS
    ALCOLADO, JC
    PACY, PJ
    BEEVERS, M
    DODSON, PM
    DIABETIC MEDICINE, 1992, 9 (10) : 904 - 907
  • [37] Metformin Reduces Cardiometabolic Risk Factors in People at High Risk for Development of Type 2 Diabetes and Cardiovascular Disease
    Kamenova, Petya
    Atanasova, Iliyana
    Kirilov, Georgi
    JOURNAL OF DIABETES & METABOLISM, 2014, 5 (12)
  • [38] Reductions in biomarkers, of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study
    Goldstein, Barry J.
    Weissman, Peter N.
    Wooddell, Margaret J.
    Waterhouse, Brian R.
    Cobitz, Alexander R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (09) : 1715 - 1723
  • [39] Concord Grape Juice Polyphenols and Cardiovascular Risk Factors: Dose-Response Relationships
    Blumberg, Jeffrey B.
    Vita, Joseph A.
    Chen, C. -Y. Oliver
    NUTRIENTS, 2015, 7 (12) : 10032 - 10052
  • [40] Incidence of and risk factors for type-2 diabetes in a general population: The Tromso Study
    Joseph, Josepha
    Svartberg, Johan
    Njolstad, Inger
    Schirmer, Henrik
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2010, 38 (07) : 768 - 775
12345